Proventil HFA Use Comprises 8-10% Of Albuterol Market - FDA's Meyer
Executive Summary
The only non-CFC albuterol metered-dose inhaler Proventil HFA captured 8% -10% of the albuterol market, FDA Pulmonary-Allergy Drug Product Division Director Robert Meyer, MD, told FDA's Pulmonary-Allergy Drugs Advisory Committee Nov. 22.